Valuation Metrics
Financials
Trading Trends
SCNI News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Scinai Immunotherapeutics Ltd (SCNI) stock price today?
The current price of SCNI is 0.762 USD — it has decreased -5.34 % in the last trading day.
What is Scinai Immunotherapeutics Ltd (SCNI)'s business?
Scinai Immunotherapeutics Ltd, formerly known as BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company that is principally focused on developing, manufacturing, and commercializing medical products for the prevention and treatment of autoimmune and infectious diseases but also for other illnesses. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The Company's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.
What is the price predicton of SCNI Stock?
Wall Street analysts forecast SCNI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SCNI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Scinai Immunotherapeutics Ltd (SCNI)'s revenue for the last quarter?
Scinai Immunotherapeutics Ltd revenue for the last quarter amounts to 206.00K USD, decreased % YoY.
What is Scinai Immunotherapeutics Ltd (SCNI)'s earnings per share (EPS) for the last quarter?
Scinai Immunotherapeutics Ltd. EPS for the last quarter amounts to -0.00 USD, decreased -100.00 % YoY.
What changes have occurred in the market's expectations for Scinai Immunotherapeutics Ltd (SCNI)'s fundamentals?
How many employees does Scinai Immunotherapeutics Ltd (SCNI). have?
Scinai Immunotherapeutics Ltd (SCNI) has 31 emplpoyees as of January 10 2026.
What is Scinai Immunotherapeutics Ltd (SCNI) market cap?
Today SCNI has the market capitalization of 2.64M USD.

![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260107205046_24132997de6359af22a4d7db8fbd5f42.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)